Note: Although all efforts have been made to present the correct data and information, this document has not been professionally edited or proof-read. Should readers come across specific errors, please contact us and we will rectify the errors immediately.
Errata Chapter: Regional Overview – East and South-East Asia p.22: "An increase in the use of nimetazepam, sometimes in combination with methamphetamine, has been reported in Brunei, Indonesia, Malaysia and Singapore...", corrected as An increase in the use of nimetazepam, sometimes in combination with methamphetamine, has been reported in Brunei, Indonesia and Malaysia. Chapter: Philippines p.98, table 81: Crystalline methamphetamine – main route of administration, injected, corrected as smoked Chapter: Singapore p. 122, table 86: Heroin – mode of administration, injected, corrected as: smoked Buprenorphine – mode of administration, injested, corrected as: injected
Printed: November 2009 Authorship: Global SMART Programme Global team: Dr. Justice Tettey, Chief, Laboratory and Scientific Section Dr. Barbara Remberg, Scientific Affairs Officer Mr. Matthew Nice, ATS Expert East Asia team: Ms. Deepika Naruka, Regional Programme Coordinator Mr. Tun Nay Soe, Information and Database Systems Specialist Mr. Johannes Lund, ATS Analyst
Disclaimer: This document has not been formally edited. The designations employed and the presentation of the material in the document does not employ the expression of any opinion on the part of the United Nations concerning the legal status of any country, territory, city or area under its authority or concerning the delimitations of its frontiers and boundaries.
Patterns and Trends of Amphetamine-Type Stimulants and Other Drugs in East and South-East Asia (and neighbouring regions) 2009
A Report from the Global SMART Programme November 2009
United Nations Office on Drugs and Crime
Table of contents

下一页